Illumina widens access to cancer tests with Medicare and new CDx
Illumina is expanding access to its oncology range of IVD tests, as its TruSight Oncology Comprehensive IVD is now covered under Medicare. The post Illumina widens access to cancer tests with Medicare and new CDx appeared first on Medical Device Network.

The post Illumina widens access to cancer tests with Medicare and new CDx appeared first on Medical Device Network.